A Phase II Study on Dose Optimization of Fruquintinib in Elderly mCRC Patients Refractory to Standard Treatment（DOFEMCRC）
Clinical trial NCT05025631 · COMPLETED
Trial details
- NCT number
- NCT05025631
- Sponsor
- Zhen-Yu Ding
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-06
- Primary completion
- 2022-10-30
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.